Director/PDMR Shareholding

RNS Number : 3139Y

AstraZeneca PLC

28 February 2012

 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

The interest of David Brennan, a Director of the Company, in AstraZeneca PLC Ordinary Shares of $0.25 each, has changed as detailed below. 

On 27 February 2012, Mr Brennan received shares from the vesting of a previously announced award made in February 2009 under the AstraZeneca Deferred Bonus Plan whereby he has now become beneficially entitled to the shares.  Sufficient shares were withheld to cover certain tax obligations arising on the vesting.

Name of Director	Number of shares vested	Number of shares withheld	Net number of shares	Market price on vesting
David R Brennan	17,992	9,409	8,583	2856p

Mr Brennan has interests in both the Ordinary Shares and the American Depositary Shares (ADSs) of AstraZeneca PLC.  One ADS equals one Ordinary Share.

As a result of this transaction, Mr Brennan has an interest in 662,509 Ordinary Shares and 81,229 AstraZeneca ADSs, which together represent approximately 0.06% of the Company's issued ordinary capital.

A C N Kemp

Company Secretary

28 February 2012

 

END

 

 

RDSUWSNRUKAUUAR